Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Orga...
Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Organic Cation Transporter 1 (OCT1)
About this item
Full title
Author / Creator
Publisher
New Zealand: Dove
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove
Subjects
More information
Scope and Contents
Contents
Sorafenib, an FDA-approved drug for advanced hepatocellular carcinoma (HCC) treatment, encounters resistance in many patients. Deciphering the mechanisms underlying sorafenib resistance is crucial for devising alternative strategies to overcome it.
This study aimed to investigate sorafenib resistance mechanisms using a diverse panel of HCC cell...
Alternative Titles
Full title
Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Organic Cation Transporter 1 (OCT1)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2edb80aedf584fb8b12a6694380f2e4c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2edb80aedf584fb8b12a6694380f2e4c
Other Identifiers
ISSN
2253-5969
E-ISSN
2253-5969
DOI
10.2147/JHC.S452152
